The medical provider communicated orally with her mckesson medical surgical account representative prior to october 12, 2021 that several of her patients had developed infections at the site of administration post different types of vaccine administration within the last 6 months.The medical provider shortly after the oral conversation, provided information via email on october 12, 2021 that she believed that the mckesson labeled needles/syringes were the common factor and may be the reason for the development of these infections that resulted in abscesses.The medical provider did not provide any product lot information regarding the mckesson labeled needle/syringes nor any patient specific information regarding the adverse events.Based upon our review of shipment data for the defined time period the medical provider received two different types of needles/syringes under the mckesson label as well as two different becton dickinson labeled needles/syringes distributed by mckesson medical surgical.As a result of this complaint, we are filing an mdr for each type of the mckesson labeled needle/ syringe products received by the medical provider.
|